Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis

Surgery

Volumn 135, Issue 2, 2004, Pages 131-138

  Hackert, Thilo ^a   Werner, Jens ^a   Gebhard, Martha Maria ^a   Klar, Ernst ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; CONTRAST MEDIUM; GLYCODEOXYCHOLIC ACID; HEPARIN; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; EDEMA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOTHELIUM; ERYTHROCYTE; HISTOLOGY; INFLAMMATION; LEUKOCYTE; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREAS INJURY; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

EID: 1642560957     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2003.08.001     Document Type: Article

References (35)

1. Zinsser E, Hoffmann A, Will U, Bosseckert H. Success and complication rates of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography - a prospective study. Z Gastroenterol 1999;37:707-13.
2. Rabenstein T, Schneider HT, Bulling D, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 2000;32:10-9.
3. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
4. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopan-creatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996;335:919-23.
5. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 1993;54:105-11.
6. Dumot JA, Conwell DL, O'Connor JB, Ferguson DR, Vargo JJ, Barnes DS, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998;93:61-5.
7. Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 1994;26:715-8.
8. Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kubler W, et al. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 1999;100: 1533-9.
9. Kinalska I, Gabryelewicz A. The effect of heparin on lipid metabolism in acute experimental pancreatitis (AEP). Z Exp Chir 1980;13:191-6.
10. Gabryelewicz A, Kosidlo S, Prokopowicz J, Podkowicz K. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats. Hepatogastroenterology 1986;33:79-82.
11. Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg 1990;77:1205-10.
12. Klar E, Werner J. New pathophysiologic knowledge about acute pancreatitis. Chirurg 2000;71:253-64.
13. Butcher EC, Weissman IL. Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J Immunol Methods 1980;37:97-108.
14. Mithofer K, Schmidt J, Gebhard MM, Buhr HJ, Herfarth C, Klar E. Measurement of blood flow in pancreatic exchange capillaries with FITC-labeled erythrocytes. Microvasc Res 1995;49:33-48.
15. Mithofer K, Schmidt J, Gebhard MM, Buhr HJ, Herfarth C, Klar E. Diaspirin crosslinked hemoglobin: evaluation of effects on the microcirculation of striated muscle. Artif Cells Blood Substit Immobil Biotechnol 1994;22: 587-92.
16. Baatz H, Steinbauer M, Harris AG, Krombach F. Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int of Microcirc Clin Exp 1995;15:85-91.
17. Schmidt J, Ryschich E, Sinn HP, Maksan S, Herfarth C, Klar E. Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic injury in necrotizing pancreatitis of the rat. Dig Dis Sci 1999; 44:823-9.
18. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215:44-56.
19. Werner J, Schmidt J, Warshaw AL, Gebhard MM, Herfarth C, Klar E. The relative safety of MRI contrast agent in acute necrotizing pancreatitis. Ann Surg 1998;227:105-11.
20. Bloechle C, Kusterer K, Kuehn RM, Schneider C, Rnoefel WT, Izbicki JR. Inhibition of bradykinin B2 receptor preserves microcirculation in experimental pancreatitis in rats. Am J Physiol 1998;274(1 Pt 1):G42-51.
21. Barkin JS, Casai GL, Reiner DK, Goldberg RI, Phillips RS, Kaplan S. A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol 1991;86:1437-41.
22. Luthen R, Niederau C, Niederau M, Ferrell LD, Grendell JH. Influence of ductal pressure and infusates on activity and subcellular distribution of lysosomal enzymes in the rat pancreas. Gastroenterology 1995;109:573-81.
23. Merriam LT, Wilcockson D, Samuel I, Joehl RJ. Ligation-induced acute pancreatitis increases pancreatic circulating trypsinogen activation peptides. J Surg Res 1996;60:417-21.
24. Quader MA, Stump LS, Sumpio BE. Low molecular weight heparins: current use and indications. J Am Coll Surg 1998;187:641-58. Review.
25. Hull RD, Pineo GF, Valentine KA. Treatment and prevention of venous thromboembolism. Semin Thromb Hemost 1998;24(Suppl 1):21-31. Review.
26. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001:8:187-94.
27. Glasbrenner B, Adler G. Pathophysiology of acute pancreatitis. Hepatogastroenterology 1993;40:517-21.
28. Klar E, Schratt VV, Foitzik T, Buhr H, Herfarth C, Messmer K. Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig Dis Sci 1994;39:2639-44.
29. Sternbergh WC, 3rd, Sobel M, Makhoul RG. Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction. J Vasc Surg 1995;21:477-83.
30. Becker M, Menger MD, Lehr HA. Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium. Am J Physiol 1994;267(3 Pt 2): H925-30.
31. Bleeker WK, Agterberg J, Rigter G, Hack CE, Gool JV. Protective effect of antithrombin III in acute experimental pancreatitis in rats. Dig Dis Sci 1992;37:280-5.
32. Klar E, Mall G, Messmer K, Herfarth C, Rattner DW, Warshaw AL. Improvement of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis. Surg Gynecol Obstet 1993;176:144-50.
33. Weiler JM, Edens RE, Linhardt RJ, Kapelanski DP. Heparin and modified heparin inhibit complement activation in vivo. J Immunol 1992;148:3210-5.
34. Imai T, Hirata Y, Emori T, Marumo F. Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. Hypertension 1993;21:353-8.
35. Liu XH, Nakano I, Ito T, Yamaguchi H, Migita Y, Miyahara T, et al. Role of endothelin in the development of hemorrhagic pancreatitis in rats. J Gastroenterol 1995; 30:275-7.